Research · 2026-04-16
By Alice Kay · Last reviewed 16 Oct 2026
DSIP in sleep-architecture lab literature
Research-use notice: This article summarizes published scientific literature for educational purposes. It is not medical advice and does not provide dosing, administration or human-use information. Findings described in the literature do not apply to any BlueNex Labs product, which is supplied only for in-vitro laboratory research and not for human or animal use.
Direct answer
Delta sleep-inducing peptide is a nonapeptide named from historical delta-wave electrophysiology papers. Laboratory context for the catalogue SKU — not a consumer sleep product.
Scope
Cognitive & neuroscience models. Sleep-architecture and neuroendocrine peptides discussed in laboratory literature.
This note does not claim that Alice Kay authored any cited paper.
DSIP Research Overview
Delta sleep-inducing peptide is a nonapeptide named from historical delta-wave electrophysiology. That naming history is why the sequence is studied; it does not make the solid a sleep product.
This page provides laboratory-focused information for DSIP. Content is intended for research use only and should be read with the published documentation and analytical data.
Delta sleep-inducing peptide (DSIP) is a nine-residue peptide first described in connection with delta-wave electrophysiology. The common name records that experimental history. It does not mean a lyophilized vial is a hypnotic, a rest aid, or a product for personal use.
BlueNex Labs lists DSIP 10 mg in the cognitive and neuroscience catalogue as a research-use-only solid for in-vitro and biochemical work. Neighbouring secretagogue SKUs such as CJC-1295 without DAC / ipamorelin are grouped by receptor class. Category grouping is taxonomy, not a combined protocol.
What published models actually measure
Primary DSIP papers discuss peptide detection in biological samples, proposed signalling hypotheses, and sleep-architecture measurements in defined animal or in-vitro systems. Those endpoints belong to the study design. They are not consumer outcomes and they are not instructions.
Conventional hypnotic drugs act through different receptor systems. This catalogue does not compare DSIP with medicines, and it does not rank “sleep peptides.” When a methods paper reports endocrine readouts during slow-wave sleep, that is an observation in that paper. It is not a reason to describe a secretagogue SKU as an overnight product.
Lot documentation
If a laboratory orders DSIP, match the vial to the Certificate of Analysis library when a Janoshik link exists. Identity and purity reports are lot-specific. A report for another peptide does not document DSIP.
Orders are fulfilled in Canada only, paid by Interac e-Transfer, and labelled research use only. Sold-out vials stay on the shop card and cannot be added to the cart.
Further reading
See How do peptides work? for a receptor-level primer and the FAQ for RUO, shipping, and COA verification.
Catalogue cross-reference
If a purchasing office needs the documented DSIP solid, open the DSIP 10 mg product page for size, price, and stock. Neighbouring neuroscience SKUs stay on their own URLs.
Orders ship inside Canada only after Interac e-Transfer checkout. Sold-out SKUs remain listed and cannot be added to the cart. Match each vial to its own Certificate of Analysis when a lot is published. Research use only. Not for human or veterinary use.
References
This note does not add a separate citation list. Named papers, when the body links them, stay in the text above.
Research use only. BlueNex Labs does not provide medical or veterinary advice. Confirm your institution’s policies before purchase. Lot-file rules for this note are on the documentation standards page. By Alice Kay.